[go: up one dir, main page]

NO20032292L - Anvendelse av Rosuvastatin (ZD-4522) ved behandling av heterozygot famili¶rhyperkolesterolemi - Google Patents

Anvendelse av Rosuvastatin (ZD-4522) ved behandling av heterozygot famili¶rhyperkolesterolemi

Info

Publication number
NO20032292L
NO20032292L NO20032292A NO20032292A NO20032292L NO 20032292 L NO20032292 L NO 20032292L NO 20032292 A NO20032292 A NO 20032292A NO 20032292 A NO20032292 A NO 20032292A NO 20032292 L NO20032292 L NO 20032292L
Authority
NO
Norway
Prior art keywords
rosuvastatin
treatment
heterozygous familial
familial hypercholesterolaemia
hypercholesterolaemia
Prior art date
Application number
NO20032292A
Other languages
English (en)
Other versions
NO20032292D0 (no
NO326245B1 (no
Inventor
Ali Raza
Howard Gerard Hutchinson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9903629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032292(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20032292D0 publication Critical patent/NO20032292D0/no
Publication of NO20032292L publication Critical patent/NO20032292L/no
Publication of NO326245B1 publication Critical patent/NO326245B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20032292A 2000-11-22 2003-05-21 Anvendelse av et statin for fremstilling av et medikament ved behandling av heterozygot familiaer hyperkolesterolemi NO326245B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0028429.9A GB0028429D0 (en) 2000-11-22 2000-11-22 Therapy
PCT/GB2001/005041 WO2002041895A1 (en) 2000-11-22 2001-11-16 Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia

Publications (3)

Publication Number Publication Date
NO20032292D0 NO20032292D0 (no) 2003-05-21
NO20032292L true NO20032292L (no) 2003-07-17
NO326245B1 NO326245B1 (no) 2008-10-27

Family

ID=9903629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032292A NO326245B1 (no) 2000-11-22 2003-05-21 Anvendelse av et statin for fremstilling av et medikament ved behandling av heterozygot familiaer hyperkolesterolemi

Country Status (34)

Country Link
US (1) US6858618B2 (no)
EP (1) EP1339409B1 (no)
JP (2) JP5062940B2 (no)
KR (1) KR100815042B1 (no)
CN (1) CN1268339C (no)
AR (1) AR031766A1 (no)
AT (1) ATE394103T1 (no)
AU (2) AU2002214165B9 (no)
BG (1) BG66009B1 (no)
BR (1) BR0115511A (no)
CA (1) CA2429263C (no)
CY (1) CY1110428T1 (no)
CZ (1) CZ301583B6 (no)
DE (1) DE60133921D1 (no)
DK (1) DK1339409T3 (no)
EE (1) EE05507B1 (no)
ES (1) ES2305118T3 (no)
GB (1) GB0028429D0 (no)
HU (1) HUP0301380A3 (no)
IL (2) IL155919A0 (no)
IS (1) IS6819A (no)
MX (1) MXPA03004336A (no)
MY (1) MY134902A (no)
NO (1) NO326245B1 (no)
NZ (1) NZ525754A (no)
PL (1) PL365386A1 (no)
PT (1) PT1339409E (no)
RU (1) RU2294744C2 (no)
SI (1) SI1339409T1 (no)
SK (1) SK6212003A3 (no)
TW (1) TWI238720B (no)
UA (1) UA75614C2 (no)
WO (1) WO2002041895A1 (no)
ZA (1) ZA200303636B (no)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
US20090247488A1 (en) * 2003-04-25 2009-10-01 Carina Cannizzaro Anti-inflammatory phosphonate compounds
US20050261237A1 (en) * 2003-04-25 2005-11-24 Boojamra Constantine G Nucleoside phosphonate analogs
US7407965B2 (en) * 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7470724B2 (en) * 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
US7452901B2 (en) * 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
CA2523083C (en) 2003-04-25 2014-07-08 Gilead Sciences, Inc. Antiviral phosphonate analogs
KR20060022647A (ko) * 2003-04-25 2006-03-10 길리애드 사이언시즈, 인코포레이티드 키나아제 억제 포스포네이트 유사체
EP1562912A2 (en) * 2003-08-28 2005-08-17 Teva Pharmaceutical Industries Limited Process for preparation of rosuvastatin calcium
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
US7432273B2 (en) * 2003-10-24 2008-10-07 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
US7777034B2 (en) 2003-11-24 2010-08-17 Teva Pharmaceutical Industries Ltd. Crystalline ammonium salts of rosuvastatin
WO2005056534A1 (en) * 2003-12-02 2005-06-23 Teva Pharmaceutical Industries Ltd. Reference standard for characterization of rosuvastatin
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
WO2005115377A1 (en) * 2004-05-26 2005-12-08 Kgk Synergize Inc Functional foods comprising flavonoids and tocotrienols and methods thereof
WO2006017357A1 (en) * 2004-07-13 2006-02-16 Teva Pharmaceutical Industries Ltd. A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step
AP2412A (en) 2004-07-27 2012-06-01 Gilead Sciences Inc Phosphonate analogs of HIV inhibitor compounds.
KR100945763B1 (ko) * 2005-02-22 2010-03-08 테바 파마슈티컬 인더스트리즈 리미티드 로수바스타틴의 제조 방법
US20070037979A1 (en) * 2005-02-22 2007-02-15 Valerie Niddam-Hildesheim Preparation of rosuvastatin
US20070167625A1 (en) * 2005-02-22 2007-07-19 Anna Balanov Preparation of rosuvastatin
EP1805148A2 (en) * 2005-08-16 2007-07-11 Teva Pharmaceutical Industries Ltd. Crystalline rosuvastatin intermediate
US9427437B2 (en) 2008-01-31 2016-08-30 The Trustees Of The University Of Pennsylvania Hypercholesterolemia and tendinous injuries
US8383614B2 (en) * 2008-01-31 2013-02-26 The Trustees Of The University Of Pennsylvania Hypercholestrolemia and tendinous injuries
US8653265B2 (en) 2008-05-27 2014-02-18 Changzhou Pharmaceutical Factory Preparation method of rosuvastatin calcium and its intermediates
EP2307435B1 (en) 2008-07-08 2012-06-13 Gilead Sciences, Inc. Salts of hiv inhibitor compounds
FI4406594T3 (fi) 2012-09-17 2025-11-26 Madrigal Pharmaceuticals Inc Kilpirauhashormonin analogeja
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose
US10600502B2 (en) 2016-12-20 2020-03-24 Astrazeneca Uk Ltd. Systems and methods for dispensing a statin medication over the counter
PL3661937T3 (pl) 2017-08-01 2021-12-20 Gilead Sciences, Inc. Formy krystaliczne ((s)-((((2r,5r)-5-(6-amino-9h-puryn-9-ylo)-4-fluoro-2,5-dihydrofuran-2-ylo)oksy)metylo)(fenoksy)fosforylo)-l-alaninianu etylu (gs-9131) do leczenia zakażeń wirusowych
CA3141505A1 (en) 2019-05-27 2020-12-03 Immatics US, Inc. Viral vectors and their use in adoptive cellular therapy
DE102020111571A1 (de) 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
US20220008519A1 (en) 2020-07-09 2022-01-13 Costa Rican Social Security Fund / Caja Costarricense de Seguro Social (CCSS) Treatment of severe acute respiratory syndrome-related coronavirus infection with klotho
WO2022040631A1 (en) 2020-08-21 2022-02-24 Immatics US, Inc. Methods for isolating cd8+ selected t cells
WO2022165227A1 (en) * 2021-02-01 2022-08-04 Madrigal Pharmaceuticals, Inc. Therapeutic combinations of rosuvastatin and resmetirom for the treatment of liver disorders or lipid disorders
US12377104B1 (en) 2024-02-06 2025-08-05 Madrigal Pharmaceuticals, Inc. Methods for treating a fatty liver disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2051907C1 (ru) * 1989-05-22 1996-01-10 Сандос АГ Способ получения 7-замещенной гептен-6-овой кислоты
JP2648897B2 (ja) * 1991-07-01 1997-09-03 塩野義製薬株式会社 ピリミジン誘導体
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
AU6294501A (en) * 2000-09-20 2002-04-02 Rtp Pharma Inc Spray drying process and compositions of fenofibrate

Also Published As

Publication number Publication date
HUP0301380A3 (en) 2007-03-28
BG107811A (bg) 2004-03-31
JP5062940B2 (ja) 2012-10-31
EE200300239A (et) 2003-08-15
MXPA03004336A (es) 2003-08-19
EE05507B1 (et) 2012-02-15
KR100815042B1 (ko) 2008-03-18
AU2002214165B2 (en) 2006-12-14
NZ525754A (en) 2004-10-29
ES2305118T3 (es) 2008-11-01
HUP0301380A2 (hu) 2003-10-28
CN1268339C (zh) 2006-08-09
NO20032292D0 (no) 2003-05-21
MY134902A (en) 2007-12-31
AR031766A1 (es) 2003-10-01
IL155919A0 (en) 2003-12-23
CA2429263A1 (en) 2002-05-30
JP2010031047A (ja) 2010-02-12
CA2429263C (en) 2009-03-17
BR0115511A (pt) 2003-12-30
DE60133921D1 (de) 2008-06-19
BG66009B1 (bg) 2010-10-29
ZA200303636B (en) 2004-08-12
CZ20031406A3 (cs) 2003-09-17
IL155919A (en) 2009-09-01
IS6819A (is) 2003-05-19
AU2002214165B9 (en) 2013-07-04
SI1339409T1 (sl) 2008-08-31
EP1339409A1 (en) 2003-09-03
TWI238720B (en) 2005-09-01
HK1056691A1 (en) 2004-02-27
WO2002041895A1 (en) 2002-05-30
ATE394103T1 (de) 2008-05-15
DK1339409T3 (da) 2008-09-08
US6858618B2 (en) 2005-02-22
RU2294744C2 (ru) 2007-03-10
US20040072852A1 (en) 2004-04-15
UA75614C2 (uk) 2006-05-15
CY1110428T1 (el) 2015-04-29
EP1339409B1 (en) 2008-05-07
KR20030048479A (ko) 2003-06-19
GB0028429D0 (en) 2001-01-10
NO326245B1 (no) 2008-10-27
SK6212003A3 (en) 2003-11-04
CN1630520A (zh) 2005-06-22
PL365386A1 (en) 2005-01-10
AU1416502A (en) 2002-06-03
PT1339409E (pt) 2008-07-07
CZ301583B6 (cs) 2010-04-21
JP2004522714A (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
NO20032292D0 (no) Anvendelse av Rosuvastatin (ZD-4522) ved behandling av heterozygot famili¶rhyperkolesterolemi
NO20034166L (no) Molekyl¶re konjugater for anvendelse ved behandling av cancer
NO20015046L (no) Integrert pumpeutstyr for bruk ved pumping av flere forskjellige fluider
NO20031193L (no) B¶rbar hårtörrer
DE60010451D1 (de) Chirurgische zugangsvorrichtung
NO20042710L (no) Dosimeterlapp til engangsbruk til bruk ved straleterapi
NO20021964L (no) Biologisk fluidbehandling
ID26300A (id) Benda penyerap sekali pakai
PL356784A1 (pl) Substancja do zastosowania w leczeniu łuszczycy
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EE200300474A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
DE69921915D1 (de) Photokatalytische Anregungsvorrichtung
NO20024455D0 (no) V¶skeströmningsregulator
NO20035501D0 (no) Vaskev¶skefordelingssystem
NO20024231D0 (no) Lipidb¶rer
DE10085461T1 (de) Chirurgische Zugangsvorrichtung
DE50005409D1 (de) Hör-behandlungsgerät
NO20022363L (no) Tannimplantatb¶rersammenstilling
NO20041840L (no) Rosuvastatin ved predemente tilstander
DE50108402D1 (de) N-alkoxyalkyl-substituierte benzimidazole und ihre verwendung als mittel gegen parasitäre protozoen
AU2002248723A8 (en) Molecules for disease detection and treatment
EP1552845A4 (en) MEANS FOR THE PREVENTION / TREATMENT OF CANCER
NO20014247D0 (no) Anordning ved törrklosett/biologisk toalett
IT1310450B1 (it) Dispositivo per il lavaggio di strumenti e/o accessori ambulatoriali.
DE69933934D1 (de) Handbrause und Filtergehäuse

Legal Events

Date Code Title Description
MK1K Patent expired